Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting
01 avr. 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer
03 mars 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Synlogic To Present at Upcoming Investor and Industry Conferences
24 févr. 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
Augusta Fermentation Qualified Opportunity Fund (QOF) Announces First Investment into the Manus Bio Qualified Opportunity Zone Business (QOZB).
23 nov. 2020 10h34 HE
|
Augusta Fermentation QZ, LLC
WAYNE, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Augusta Fermentation Opportunity Zone Fund I, L.P. (AF I) today announced it has acquired an equity interest in Manus Bio’s QOZB which operates a...
Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design
28 nov. 2017 14h33 HE
|
Arzeda
SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. ...
Embracing Open-Source Biotech: DNA Freeware May Out-Innovate Patented Genes
27 août 2013 07h30 HE
|
Lux Research
BOSTON, MA--(Marketwired - Aug 27, 2013) - With synthetic biology (synbio) rapidly gaining momentum, and a landmark U.S. Supreme Court judgment striking down an age-old biological patenting system,...